Business Wire

NY-CONDECO

12.4.2022 14:32:04 CEST | Business Wire | Press release

Share
Condeco Launches New Marketing Campaign to Address the Greatest Cultural Shift in Business of the 21st Century

Condeco , a global leader in workspace scheduling software, is today announcing the launch of its new marketing campaign that is uniquely designed to address the immediate need for businesses to redefine the workplace and respond to the evolving expectations of their employees.

Condeco’s campaign will debut with a new film short that showcases the needs of the modern workplace and contextualizes the new wave of business culture that is turning the traditional office environment on its head. Positioned as a satirical comedy, the film short highlights the growing generational divide that has emerged out of the pandemic, and light-heartedly cements the importance of having an employer that understands and embraces employee needs.

In addition to the launch of this new film, Condeco’s new marketing campaign includes a new consumer report that supports the importance of fostering a workplace that respects the desires of its employees, with hybrid work opportunities at its core. As full-time remote work becomes a pandemic pastime, this report’s findings underscore the need for business leaders to prioritize employee happiness, mental health, and digital technology as they adopt hybrid work models.

“It’s no secret that there has been a seismic shift in how we work” said Lynda Lowe, CMO at Condeco. “Work is now an outcome that is no longer defined by a single physical location and there is a growing tension point between business leaders who are trying to force a return to the office and their employees who want to be able to work flexibly. But this does not mean that leaders should discount the value of the office altogether. Instead, leaders must understand the value of the office has shifted to providing a safe space for employee collaboration. The past two years have taught us that empowering employees with time and space to do this at their choosing is key to supporting their mental health and well-being, as well as driving enhanced business culture and social interaction.”

Condeco’s new marketing campaign follows the brand’s repositioning in 2021 , which recognized the immediate need for employers to provide their employees with the flexibility to work from anywhere. Delivering on its mission to help businesses redefine their workplace, Condeco acquired ProxyClick in January 2022 to expand Condeco’s workspace solutions for the enterprise, enabling the company to drive an end-to-end employee and guest experience with the connected office – and ultimately, help businesses prepare for the future at work.

Condeco’s new film will air across connected TV and social channels starting on Tuesday, April 12, 2022. Media planned and bought by Hubble , part of What’s Possible Group. The film was produced by Arts & Sciences and directed by Casey Storm, who is known for his work with brands including Paypal, Apple, Hulu, Expedia, and more.

To view the full broadcast, please see here: https://youtu.be/HunkSOvLJ4M . To learn more about Condeco’s new report on hybrid work, please see here .

About Condeco

Condeco is the global leader in enterprise level workspace solutions. Our software is designed to equip everyone with the tools they need for a seamless end to end experience in today’s office. By giving people control over flexible work, we deliver the certainty people need, enable the collaboration teams crave, and facilitate the insights on capacity that employers demand. From visitor management to workspace booking to office optimization, we are trusted by over 2000 of the world’s largest companies to realize their future at work.

About Arts & Sciences

Arts & Sciences was started over a decade ago as a boutique production company that specializes in producing award-winning advertising content, music videos, fine art projects, original documentaries, and feature films. Located in Los Angeles, NYC, and London, Arts & Sciences represents a diverse group of top directors and creators and has been named a Creativity A-List Production Company five times. Every major advertising award show has recognized its work, including Cannes Lions, Clio, AICP, D&AD, The One Show, and the Andys. Their original content work has been featured in the New Frontiers showcase at the Sundance Film Festival, The New Yorker, Nowness, and Purple Magazine. Arts & Sciences has produced work for every major global brand, such as Google, Apple, Facebook, Nike, AT&T, Samsung, Volkswagen, Ford, Toyota, American Express, MLB, the NFL, and more.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 16:00:00 CEST | Press release

Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me

BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 15:34:00 CEST | Press release

Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro

Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 11:00:00 CEST | Press release

Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026 The approval is based on data from the Phase 3 RISE-PD trial where Hopledo® demonstrated a significant increase in Good ON time compared with immediate-release LD/CD with fewer daily doses and a comparable safety profile Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely

MTG-I2 Safely in Orbit, Unlocking Faster and Sharper Weather Monitoring Across Europe28.8.2026 10:16:00 CEST | Press release

The Meteosat Third Generation Imager 2 satellite (MTG-I2) has successfully passed its first critical post-launch milestones, completing the first full Meteosat Third Generation constellation in orbit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828243790/en/ Credit: Arianespace livestream The imager satellite MTG-I2 is safely in orbit and operating as expected following its successful launch yesterday at 22:11 CEST on board an Ariane 6 rocket from Europe’s Spaceport in French Guiana. Our teams have established communication with the spacecraft, which has also deployed its solar panels to ensure its autonomous production of energy. MTG-I2 is in perfect shape to start its Launch and Early Operations Phase that will bring it to a higher orbit, 36 000km above Earth over the following two weeks, where a longer period of calibration and validation of its instruments will begin. This summer’s extreme weather and wildfires hav

New Daiichi Sankyo Data Underscore the Effect of Bempedoic Acid in the Real-World Management of Dyslipidemia and Cardiovascular risk28.8.2026 10:00:00 CEST | Press release

Analyses from the multinational MILOS study show that LDL-C reductions achieved with up to one year of treatment with bempedoic acid-containing therapies translate to a 17.1% relative reduction and a 4.8% absolute reduction in predicted 10-year cardiovascular risk.1 Real-world data demonstrated clinically relevant mean LDL-C reductions of at least 24.9%, regardless of patient gender or glycaemic status, after one year of follow-up.2,3 Findings presented at ESC Congress 2026 reinforce the clinical value of bempedoic acid in routine clinical practice, and demonstrate the continued investment of Daiichi Sankyo in addressing outstanding unmet needs in cardiovascular disease (CVD). Daiichi Sankyo (TSE:4568) today announced new results from the MILOS study that demonstrate the real-world impact of bempedoic acid administered either alone or as a fixed-dose combination with ezetimibe, in the management of dyslipidaemia. Presented at the European Society of Cardiology Congress 2026 in Munich,

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye